Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1886 1
1891 1
1946 2
1948 1
1949 2
1950 1
1951 1
1952 3
1953 1
1955 1
1956 1
1957 2
1958 1
1960 1
1962 1
1964 2
1965 3
1966 1
1969 1
1970 3
1972 2
1973 3
1974 1
1975 2
1976 1
1977 3
1978 7
1979 2
1980 6
1981 8
1982 1
1983 2
1984 6
1985 8
1986 3
1987 6
1988 7
1989 10
1990 10
1991 5
1992 10
1993 12
1994 18
1995 13
1996 17
1997 18
1998 23
1999 13
2000 23
2001 36
2002 34
2003 28
2004 26
2005 46
2006 56
2007 47
2008 33
2009 44
2010 47
2011 43
2012 34
2013 44
2014 34
2015 34
2016 51
2017 35
2018 43
2019 40
2020 42
2021 62
2022 28
2023 33
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

1,133 results

Results by year

Filters applied: . Clear all
Page 1
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.
Cichocki F, Zhang B, Wu CY, Chiu E, Day A, O'Connor RS, Yackoubov D, Simantov R, McKenna DH, Cao Q, Defor TE, Janakiram M, Wangen R, Cayci Z, Snyder N, Kumar A, Grzywacz B, Hwang J, Geffen Y, Miller JS, Maakaron J, Bachanova V. Cichocki F, et al. Among authors: miller js. Sci Transl Med. 2023 Jul 19;15(705):eade3341. doi: 10.1126/scitranslmed.ade3341. Epub 2023 Jul 19. Sci Transl Med. 2023. PMID: 37467318 Free PMC article.
High-dimensional single-cell analysis of human natural killer cell heterogeneity.
Rebuffet L, Melsen JE, Escalière B, Basurto-Lozada D, Bhandoola A, Björkström NK, Bryceson YT, Castriconi R, Cichocki F, Colonna M, Davis DM, Diefenbach A, Ding Y, Haniffa M, Horowitz A, Lanier LL, Malmberg KJ, Miller JS, Moretta L, Narni-Mancinelli E, O'Neill LAJ, Romagnani C, Ryan DG, Sivori S, Sun D, Vagne C, Vivier E. Rebuffet L, et al. Among authors: miller js. Nat Immunol. 2024 Aug;25(8):1474-1488. doi: 10.1038/s41590-024-01883-0. Epub 2024 Jul 2. Nat Immunol. 2024. PMID: 38956378 Free PMC article.
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia.
Cichocki F, Goodridge JP, Bjordahl R, Mahmood S, Davis ZB, Gaidarova S, Abujarour R, Groff B, Witty A, Wang H, Tuininga K, Kodal B, Felices M, Bonello G, Huffman J, Dailey T, Lee TT, Walcheck B, Valamehr B, Miller JS. Cichocki F, et al. Among authors: miller js. Blood. 2022 Dec 8;140(23):2451-2462. doi: 10.1182/blood.2021015184. Blood. 2022. PMID: 35917442 Free PMC article.
Molecule-based magnets.
Miller JS, Gatteschi D. Miller JS, et al. Chem Soc Rev. 2011 Jun;40(6):3065-6. doi: 10.1039/c1cs90019f. Epub 2011 May 9. Chem Soc Rev. 2011. PMID: 21552607 No abstract available.
Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia.
Haroun-Izquierdo A, Vincenti M, Netskar H, van Ooijen H, Zhang B, Bendzick L, Kanaya M, Momayyezi P, Li S, Wiiger MT, Hoel HJ, Krokeide SZ, Kremer V, Tjonnfjord G, Berggren S, Wikström K, Blomberg P, Alici E, Felices M, Önfelt B, Höglund P, Valamehr B, Ljunggren HG, Björklund A, Hammer Q, Kveberg L, Cichocki F, Miller JS, Malmberg KJ, Sohlberg E. Haroun-Izquierdo A, et al. Among authors: miller js. J Immunother Cancer. 2022 Nov;10(11):e005577. doi: 10.1136/jitc-2022-005577. J Immunother Cancer. 2022. PMID: 36319065 Free PMC article.
Cellular Immunotherapy-Highlights from TCT 2021.
Reshef R, Muranski P, Miller JS. Reshef R, et al. Among authors: miller js. Transplant Cell Ther. 2021 Jul;27(7):527-532. doi: 10.1016/j.jtct.2021.04.015. Epub 2021 Apr 26. Transplant Cell Ther. 2021. PMID: 33915324 Free article. No abstract available.
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
Snyder KM, Dixon KJ, Davis Z, Hosking M, Hart G, Khaw M, Matson A, Bjordahl R, Hancock B, Shirinbak S, Miller JS, Valamehr B, Wu J, Walcheck B. Snyder KM, et al. Among authors: miller js. J Immunother Cancer. 2023 Dec 6;11(12):e007280. doi: 10.1136/jitc-2023-007280. J Immunother Cancer. 2023. PMID: 38056893 Free PMC article.
1,133 results